Hussman Strategic Advisors, Inc. Cor Medix Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $428 Million
- Q3 2025
A detailed history of Hussman Strategic Advisors, Inc. transactions in Cor Medix Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 315,000 shares of CRMD stock, worth $3.62 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
315,000
Previous 63,000
400.0%
Holding current value
$3.62 Million
Previous $776,000
385.82%
% of portfolio
0.88%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding CRMD
# of Institutions
189Shares Held
33.6MCall Options Held
867KPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA4.33MShares$49.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.8 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$29.6 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$19.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$18.4 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $473M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...